
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a 4-Part Series
Hematologic Oncology Update
00:00
BIS Specifics - Can It Be Done in the Community?
The hope and the vision for the future is that it should be able to be used outpatient. The first few doses, I do think are going to happen at transplant centers or CAR T cell centers or academic centers before it goes out into the community. We need a little more work on trying to identify the best patients that we can do it.
Transcript
Play full episode